all 197466 studies found for:    ALL
Show Display Options
Rank Status Study
1 Recruiting Heating Precondition of Epidural Catheter Decrease the Incidence of Injury to Blood Vessel During Epidural Catheter Placement
Condition: Epidural Anesthesia
Intervention: Other: heating precondition
2 Not yet recruiting Central and Peripheral Blood Pressure in Stroke
Conditions: Stroke, Acute;   Blood Pressure
Intervention: Other: Blood pressure assessment
3 Not yet recruiting Impact of Simulator-based Training in Transoesophageal Echocardiography
Condition: Imaging of Heart Disease
Intervention: Device: Transesophageal echocardiography simulator
4 Withheld [Trial of device that is not approved or cleared by the U.S. FDA]
5 Not yet recruiting A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Obinutuzumab;   Drug: Ibrutinib
6 Not yet recruiting Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis
Condition: Malignant Melanoma
Intervention: Drug: Cobimetinib + Vemurafenib combination treatment
7 Completed Effect of Varying the Protein and Dietary Fiber Content of Energy Bars on Their Glycemic and Insulinemic Impact
Condition: Diabetes Mellitus
Interventions: Other: Control 1;   Other: Control 2;   Other: 15/0;   Other: 15/0LS;   Other: 15/5;   Other: 10/5;   Other: 10/10
8 Recruiting Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)
Condition: Opioid Use Disorder
Interventions: Drug: NTX/BUP;   Drug: NTX/PBO-B;   Drug: PBO-N/PBO-B
9 Not yet recruiting Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors
Conditions: Solid Tumors;   Carcinoma, Non-Small Cell Lung;   Non-Small Cell Lung Cancer;   Non-Small-Cell Lung Carcinoma;   Nonsmall Cell Lung Cancer
Interventions: Drug: Cisplatin;   Drug: Gemcitabine;   Drug: Talazoparib
10 Recruiting Retroperitoneal Lymph Node Dissection in Treating Patients With Stage I-IIA Testicular Seminoma
Conditions: Lymphadenopathy;   Stage I Testicular Seminoma;   Stage II Testicular Seminoma
Interventions: Other: Laboratory Biomarker Analysis;   Procedure: Retroperitoneal Lymph Node Dissection
11 Enrolling by invitation Guidelines Oriented Approach to Lipid Lowering (GOAL) in Canada
Condition: Dyslipidemia
Intervention: Other: survey
12 Recruiting Evaluation of 8.5 vs 9.0 Base Curve for 1-DAY ACUVUE(r) TruEye(r) Brand Contact Lenses
Condition: Contact Lens Base Curve (BC) Fit and Comfort
Interventions: Device: Contact Lenses with 8.5 BC;   Device: Contact Lenses with 9.0 BC
13 Not yet recruiting PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. Placebo
Condition: Atopic Dermatitis
Interventions: Drug: Cholecalciferol;   Drug: Placebo of cholecalciferol
14 Recruiting Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Use of rTMS
Condition: Alzheimer's Disease
Interventions: Procedure: Repetitive Transcranial Magnetic Stimulation;   Procedure: Repetitive Transcranial Magnetic Stimulation - Sham
15 Not yet recruiting A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: IDP-120 Gel;   Drug: IDP-120 Component A;   Drug: IDP-120 Component B;   Drug: IDP-120 Vehicle Gel
16 Recruiting Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes
Conditions: Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 2
Interventions: Drug: Biphasic Remogliflozin Etabonate;   Other: Placebo
17 Completed Bioequivalence Study of Rivaroxaban
Condition: Embolism, Atrial Fibrillation and Venous Thrombosis
Interventions: Drug: Rivaroxaban (BAY 59-7939);   Drug: Rivaroxaban (Xarelto, BAY 59-7939)
18 Not yet recruiting ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Recurrent Ovarian Cancer (KEYNOTE191)
Condition: Ovarian Cancer.
Interventions: Drug: ACP-196;   Drug: ACP-196 and pembrolizumab combination
19 Not yet recruiting Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)
Condition: X-linked Hypophosphatemia
Intervention: Biological: KRN23
20 Not yet recruiting Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Receiving Standard Chemotherapy Regimens
Condition: Solid Malignancies
Interventions: Drug: durvalumab;   Drug: tremelimumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years